by Fred Jordan | Sep 30, 2016 | Blog
Although counterfeit medicines affect every region of the world, many drug-counterfeiting rings originate in Southeast Asian countries, such as Cambodia, Thailand, Laos, Vietnam, and China.I Many factors tend to bolster this situation, including weak enforcement, lack...
by Martin Kutter | Jun 24, 2016 | Blog
Dated June 6, 2016, a “Roadmap” was published on June 9th on the EU Transparency Register covering implementing measures and delegated acts under Articles 15(11), 15(12) and 16(2) of the Tobacco Products Directive (TPD) 2014/40/EU.I In E.U. terms, “roadmaps” are...
by Fred Jordan | Apr 26, 2016 | Blog
On February 9, 2016, the countdown to implementing the safety measures mandated by the Falsified Medicines Directive (FMD) Delegated Act started. This Act, which will come into force in early 2019, imposes item-level serialization and tamper evidence on pharmaceutical...
by Martin Kutter | Mar 16, 2016 | Blog
The publication of the Delegated Regulation (EU) 2016/161I supplementing the Falsified Medicines Directive (FMD) 2001/83/EC and its amendment 2011/62/EU was finally published in the Official Journal of the European Union on February 9, 2016. This date marks the...
by Fred Jordan | Jan 22, 2016 | Blog
Our previous blog article (Cost-Benefit Analysis of a ‘European Hub’ for Medicine Authentication) analyzed the cost-benefit of creating a European hub – the European Medicines Verification Organization or EMVO – to link national verification systems throughout Europe...
by Martin Kutter | Nov 18, 2015 | Blog
As described in our previous blog (New Developments in the Fight Against Falsified Medicines), the European Medicines Verification Organisation or EMVO was founded in February 2015 as a means to help EU Member States implement the requirements set out by the Falsified...
